HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina de Min Selected Research

NI-0101

1/2020Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina de Min Research Topics

Disease

3Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2020 - 01/2017
2Infections
01/2020 - 01/2019
1Rheumatoid Arthritis
01/2020
1Histoplasmosis
01/2020
1Rheumatic Diseases (Rheumatism)
01/2020
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
05/2018
1Body Weight (Weight, Body)
01/2018
1Macrophage Activation Syndrome
01/2017
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2017

Drug/Important Bio-Agent (IBA)

2EmapalumabIBA
01/2020 - 01/2019
2InterferonsIBA
01/2020 - 01/2017
1Antigen-Antibody Complex (Immune Complex)IBA
01/2020
1C-Reactive ProteinIBA
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1NI-0101IBA
01/2020
1acetyl 4-aminosalicylic acidIBA
01/2020
1Anti-Citrullinated Protein AntibodiesIBA
01/2020
1Monoclonal AntibodiesIBA
01/2020
1Methotrexate (Mexate)FDA LinkGeneric
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020
1Toll-Like Receptor 4IBA
01/2020
1Chemokine CXCL10IBA
05/2018
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
05/2018
1Fibrinogen (Factor I)FDA Link
01/2018
1Alanine Transaminase (SGPT)IBA
01/2018
1Ferritins (Ferritin)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2017
1ChemokinesIBA
01/2017

Therapy/Procedure

1Therapeutics
01/2020
1Intravenous Administration
05/2018